管理和控制家禽中的菌病 - - 综述
Rafiq Ahmad1, Yu-Hsiang Yu1, Kuo-Feng Hua1
1Department of Biotechnology and Animal Science, National Ilan University, Yilan 26047, Taiwan.
Animal bioscience
|August 29, 2023
概括
禽类菌病是一种肠道寄生虫,会造成严重的经济损失. 像Artemisia annua这样的草药提供了一个有希望的,无化学品的替代品来控制的这种疾病.
科学领域:
- 兽医寄生虫学 兽医寄生虫学
- 禽畜科学 禽畜科学 禽畜科学
- 植物化学 植物化学
背景情况:
- 由Eimeria原生虫引起的家禽菌病导致严重的胃肠道炎症和家禽行业的经济损失.
- 传统的抗菌素化学化合物是有效的,但由于Eimeria物种的广泛耐药性,引起了人们的担忧.
- 迫切需要替代的,可持续的方法来管理和预防家禽菌病.
研究的目的:
- 审查目前关于使用植物化学品预防和治疗家禽菌病的知识.
- 评估关键草药对Eimeria物种的疗效和作用机制.
- 检查欧盟内菌病管理中植物化学品的法律框架.
主要方法:
- 科学数据库和相关出版物的文献综述.
- 对特定植物化学物质 (Artemisia annua,Bidens pilosa,大) 对Eimeria感染的影响研究的分析.
- 对草药补充剂对家禽胃肠道的作用模式的研究进行了审查.
主要成果:
- 植物化学物质通过减少Eimeria卵产量,显示出控制菌病的潜力.
- 草药补充剂可以抑制的胃肠组织中的Eimeria物种的扩散和生长.
- 这些天然化合物通过增加上皮质周转增加肠道透性,支持肠道健康.
结论:
- 草药是一种可行的,无化学物质的策略,用于预防和治疗家禽菌病.
- 了解植物化学品的作用模式对于优化它们在家禽养殖中的使用至关重要.
- 植物医药的整合符合家禽行业的可持续和"无杀虫剂化学品"标准.
相关概念视频
01:28Biological Methods for Microbial Control
62
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
62
01:29Methods for Controlling Microbial Growth
69
Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
69
01:24Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
01:28Pneumonia IV: Management
359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359